Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 10Phase NA 6Phase 1/2 6Phase EARLY_PHASE1 3Phase 3 2

Status

Completed 399Unknown 118Recruiting 91Terminated 83Active not recruiting 78Withdrawn 22Not yet recruiting 20Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Thoracic 3Other hematologic neoplasm 3Gynecologic 3Lymphoid 2Genitourinary 2Classical hematology 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other 1Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia 1

Interventions

sargramostim 1Vincristine 1Rituximab 1Prednisone 1Prednisolone 1Methylprednisolone 1Methods 1Immunotherapy, Active 1Immunization, Passive 1Drug Therapy 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Coal Tar 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Lymphoid × Clear all
NCT00324831 2013-12-18

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

National Cancer Institute (NCI)

Phase 3 Suspended
480 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡